News - Prothea Technologies

First Patient Recruited in Precision Lung Clinical Study

Prothea Technologies is pleased to announce the enrolment of the first patient in the Precision Lung clinical study (ISRCTN15093468). The study is co-sponsored by ACCORD, the joint research office between the […]

Date 15.9.25

Prothea Technologies at AABIP 2025

Prothea Technologies, the private medical technology company with a vision to offer lung cancer biopsy and treatment in a single hospital visit, is pleased to announce that its technology will feature […]

Date 12.8.25

Prothea Technologies at ECBIP 2025

Prothea Technologies, the private medical technology company with a vision to offer lung cancer biopsy and treatment in a single hospital visit, is pleased to announce that its technology will […]

Date 7.5.25

Prothea Technologies Launches with €12M Series A to Innovate Lung Cancer Diagnosis and Treatment.

Prothea Technologies launched with €12M Series A to address two main challenges in the management of lung cancer: inaccurate biopsies and limited interventional treatment options for small lesions. Round co-led […]

Date 2.9.24